Global Burosumab Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
Burosumab , a fully human IgG1 monoclonal antibody directed at fibroblast growth factor 23 (FGF23), is indicated for the treatment of X-linked hypophosphatemia (XLH), a condition associated with excessive FGF23 production.
The global market for Burosumab is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Burosumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Burosumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Burosumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Burosumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Burosumab players cover Ultragenyx and Kyowa Kirin.. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Burosumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Burosumab market, with both quantitative and qualitative data, to help readers understand how the Burosumab market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Burosumab market and forecasts the market size by Type (10mg/mL, 20mg/mL and 30mg/mL), by Application (Minor Patients Over 1 Year Old and Adult Patients.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Burosumab, Research Methodology, etc.
Chapter 2: Executive Summary, global Burosumab market size (sales and revenue) and CAGR, Burosumab market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Burosumab sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Burosumab sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Burosumab market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Ultragenyx and Kyowa Kirin etc.
Chapter 14: Research Findings and Conclusion
Burosumab , a fully human IgG1 monoclonal antibody directed at fibroblast growth factor 23 (FGF23), is indicated for the treatment of X-linked hypophosphatemia (XLH), a condition associated with excessive FGF23 production.
The global market for Burosumab is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Burosumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Burosumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Burosumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Burosumab market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Burosumab players cover Ultragenyx and Kyowa Kirin.. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Burosumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Burosumab market, with both quantitative and qualitative data, to help readers understand how the Burosumab market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Burosumab market and forecasts the market size by Type (10mg/mL, 20mg/mL and 30mg/mL), by Application (Minor Patients Over 1 Year Old and Adult Patients.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- 10mg/mL
- 20mg/mL
- 30mg/mL
- Minor Patients Over 1 Year Old
- Adult Patients
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ultragenyx
- Kyowa Kirin
Chapter 1: Scope of Burosumab, Research Methodology, etc.
Chapter 2: Executive Summary, global Burosumab market size (sales and revenue) and CAGR, Burosumab market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Burosumab sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Burosumab sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Burosumab market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Ultragenyx and Kyowa Kirin etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Burosumab Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Burosumab by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Burosumab by Country/Region, 2017, 2022 & 2028
2.2 Burosumab Segment by Type
2.2.1 10mg/mL
2.2.2 20mg/mL
2.2.3 30mg/mL
2.3 Burosumab Sales by Type
2.3.1 Global Burosumab Sales Market Share by Type (2017-2022)
2.3.2 Global Burosumab Revenue and Market Share by Type (2017-2022)
2.3.3 Global Burosumab Sale Price by Type (2017-2022)
2.4 Burosumab Segment by Application
2.4.1 Minor Patients Over 1 Year Old
2.4.2 Adult Patients
2.5 Burosumab Sales by Application
2.5.1 Global Burosumab Sale Market Share by Application (2017-2022)
2.5.2 Global Burosumab Revenue and Market Share by Application (2017-2022)
2.5.3 Global Burosumab Sale Price by Application (2017-2022)
3 GLOBAL BUROSUMAB BY COMPANY
3.1 Global Burosumab Breakdown Data by Company
3.1.1 Global Burosumab Annual Sales by Company (2020-2022)
3.1.2 Global Burosumab Sales Market Share by Company (2020-2022)
3.2 Global Burosumab Annual Revenue by Company (2020-2022)
3.2.1 Global Burosumab Revenue by Company (2020-2022)
3.2.2 Global Burosumab Revenue Market Share by Company (2020-2022)
3.3 Global Burosumab Sale Price by Company
3.4 Key Manufacturers Burosumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Burosumab Product Location Distribution
3.4.2 Players Burosumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BUROSUMAB BY GEOGRAPHIC REGION
4.1 World Historic Burosumab Market Size by Geographic Region (2017-2022)
4.1.1 Global Burosumab Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Burosumab Annual Revenue by Geographic Region
4.2 World Historic Burosumab Market Size by Country/Region (2017-2022)
4.2.1 Global Burosumab Annual Sales by Country/Region (2017-2022)
4.2.2 Global Burosumab Annual Revenue by Country/Region
4.3 Americas Burosumab Sales Growth
4.4 APAC Burosumab Sales Growth
4.5 Europe Burosumab Sales Growth
4.6 Middle East & Africa Burosumab Sales Growth
5 AMERICAS
5.1 Americas Burosumab Sales by Country
5.1.1 Americas Burosumab Sales by Country (2017-2022)
5.1.2 Americas Burosumab Revenue by Country (2017-2022)
5.2 Americas Burosumab Sales by Type
5.3 Americas Burosumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Burosumab Sales by Region
6.1.1 APAC Burosumab Sales by Region (2017-2022)
6.1.2 APAC Burosumab Revenue by Region (2017-2022)
6.2 APAC Burosumab Sales by Type
6.3 APAC Burosumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Burosumab by Country
7.1.1 Europe Burosumab Sales by Country (2017-2022)
7.1.2 Europe Burosumab Revenue by Country (2017-2022)
7.2 Europe Burosumab Sales by Type
7.3 Europe Burosumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Burosumab by Country
8.1.1 Middle East & Africa Burosumab Sales by Country (2017-2022)
8.1.2 Middle East & Africa Burosumab Revenue by Country (2017-2022)
8.2 Middle East & Africa Burosumab Sales by Type
8.3 Middle East & Africa Burosumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Burosumab
10.3 Manufacturing Process Analysis of Burosumab
10.4 Industry Chain Structure of Burosumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Burosumab Distributors
11.3 Burosumab Customer
12 WORLD FORECAST REVIEW FOR BUROSUMAB BY GEOGRAPHIC REGION
12.1 Global Burosumab Market Size Forecast by Region
12.1.1 Global Burosumab Forecast by Region (2023-2028)
12.1.2 Global Burosumab Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Burosumab Forecast by Type
12.7 Global Burosumab Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ultragenyx
13.1.1 Ultragenyx Company Information
13.1.2 Ultragenyx Burosumab Product Offered
13.1.3 Ultragenyx Burosumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Ultragenyx Main Business Overview
13.1.5 Ultragenyx Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Burosumab Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Burosumab by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Burosumab by Country/Region, 2017, 2022 & 2028
2.2 Burosumab Segment by Type
2.2.1 10mg/mL
2.2.2 20mg/mL
2.2.3 30mg/mL
2.3 Burosumab Sales by Type
2.3.1 Global Burosumab Sales Market Share by Type (2017-2022)
2.3.2 Global Burosumab Revenue and Market Share by Type (2017-2022)
2.3.3 Global Burosumab Sale Price by Type (2017-2022)
2.4 Burosumab Segment by Application
2.4.1 Minor Patients Over 1 Year Old
2.4.2 Adult Patients
2.5 Burosumab Sales by Application
2.5.1 Global Burosumab Sale Market Share by Application (2017-2022)
2.5.2 Global Burosumab Revenue and Market Share by Application (2017-2022)
2.5.3 Global Burosumab Sale Price by Application (2017-2022)
3 GLOBAL BUROSUMAB BY COMPANY
3.1 Global Burosumab Breakdown Data by Company
3.1.1 Global Burosumab Annual Sales by Company (2020-2022)
3.1.2 Global Burosumab Sales Market Share by Company (2020-2022)
3.2 Global Burosumab Annual Revenue by Company (2020-2022)
3.2.1 Global Burosumab Revenue by Company (2020-2022)
3.2.2 Global Burosumab Revenue Market Share by Company (2020-2022)
3.3 Global Burosumab Sale Price by Company
3.4 Key Manufacturers Burosumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Burosumab Product Location Distribution
3.4.2 Players Burosumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BUROSUMAB BY GEOGRAPHIC REGION
4.1 World Historic Burosumab Market Size by Geographic Region (2017-2022)
4.1.1 Global Burosumab Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Burosumab Annual Revenue by Geographic Region
4.2 World Historic Burosumab Market Size by Country/Region (2017-2022)
4.2.1 Global Burosumab Annual Sales by Country/Region (2017-2022)
4.2.2 Global Burosumab Annual Revenue by Country/Region
4.3 Americas Burosumab Sales Growth
4.4 APAC Burosumab Sales Growth
4.5 Europe Burosumab Sales Growth
4.6 Middle East & Africa Burosumab Sales Growth
5 AMERICAS
5.1 Americas Burosumab Sales by Country
5.1.1 Americas Burosumab Sales by Country (2017-2022)
5.1.2 Americas Burosumab Revenue by Country (2017-2022)
5.2 Americas Burosumab Sales by Type
5.3 Americas Burosumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Burosumab Sales by Region
6.1.1 APAC Burosumab Sales by Region (2017-2022)
6.1.2 APAC Burosumab Revenue by Region (2017-2022)
6.2 APAC Burosumab Sales by Type
6.3 APAC Burosumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Burosumab by Country
7.1.1 Europe Burosumab Sales by Country (2017-2022)
7.1.2 Europe Burosumab Revenue by Country (2017-2022)
7.2 Europe Burosumab Sales by Type
7.3 Europe Burosumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Burosumab by Country
8.1.1 Middle East & Africa Burosumab Sales by Country (2017-2022)
8.1.2 Middle East & Africa Burosumab Revenue by Country (2017-2022)
8.2 Middle East & Africa Burosumab Sales by Type
8.3 Middle East & Africa Burosumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Burosumab
10.3 Manufacturing Process Analysis of Burosumab
10.4 Industry Chain Structure of Burosumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Burosumab Distributors
11.3 Burosumab Customer
12 WORLD FORECAST REVIEW FOR BUROSUMAB BY GEOGRAPHIC REGION
12.1 Global Burosumab Market Size Forecast by Region
12.1.1 Global Burosumab Forecast by Region (2023-2028)
12.1.2 Global Burosumab Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Burosumab Forecast by Type
12.7 Global Burosumab Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ultragenyx
13.1.1 Ultragenyx Company Information
13.1.2 Ultragenyx Burosumab Product Offered
13.1.3 Ultragenyx Burosumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Ultragenyx Main Business Overview
13.1.5 Ultragenyx Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Burosumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Burosumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 10mg/mL
Table 4. Major Players of 20mg/mL
Table 5. Major Players of 30mg/mL
Table 6. Global Burosumab Sales by Type (2017-2022) & (K Units)
Table 7. Global Burosumab Sales Market Share by Type (2017-2022)
Table 8. Global Burosumab Revenue by Type (2017-2022) & ($ million)
Table 9. Global Burosumab Revenue Market Share by Type (2017-2022)
Table 10. Global Burosumab Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Burosumab Sales by Application (2017-2022) & (K Units)
Table 12. Global Burosumab Sales Market Share by Application (2017-2022)
Table 13. Global Burosumab Revenue by Application (2017-2022)
Table 14. Global Burosumab Revenue Market Share by Application (2017-2022)
Table 15. Global Burosumab Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Burosumab Sales by Company (2020-2022) & (K Units)
Table 17. Global Burosumab Sales Market Share by Company (2020-2022)
Table 18. Global Burosumab Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Burosumab Revenue Market Share by Company (2020-2022)
Table 20. Global Burosumab Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Burosumab Producing Area Distribution and Sales Area
Table 22. Players Burosumab Products Offered
Table 23. Burosumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Burosumab Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Burosumab Sales Market Share Geographic Region (2017-2022)
Table 28. Global Burosumab Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Burosumab Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Burosumab Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Burosumab Sales Market Share by Country/Region (2017-2022)
Table 32. Global Burosumab Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Burosumab Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Burosumab Sales by Country (2017-2022) & (K Units)
Table 35. Americas Burosumab Sales Market Share by Country (2017-2022)
Table 36. Americas Burosumab Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Burosumab Revenue Market Share by Country (2017-2022)
Table 38. Americas Burosumab Sales by Type (2017-2022) & (K Units)
Table 39. Americas Burosumab Sales Market Share by Type (2017-2022)
Table 40. Americas Burosumab Sales by Application (2017-2022) & (K Units)
Table 41. Americas Burosumab Sales Market Share by Application (2017-2022)
Table 42. APAC Burosumab Sales by Region (2017-2022) & (K Units)
Table 43. APAC Burosumab Sales Market Share by Region (2017-2022)
Table 44. APAC Burosumab Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Burosumab Revenue Market Share by Region (2017-2022)
Table 46. APAC Burosumab Sales by Type (2017-2022) & (K Units)
Table 47. APAC Burosumab Sales Market Share by Type (2017-2022)
Table 48. APAC Burosumab Sales by Application (2017-2022) & (K Units)
Table 49. APAC Burosumab Sales Market Share by Application (2017-2022)
Table 50. Europe Burosumab Sales by Country (2017-2022) & (K Units)
Table 51. Europe Burosumab Sales Market Share by Country (2017-2022)
Table 52. Europe Burosumab Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Burosumab Revenue Market Share by Country (2017-2022)
Table 54. Europe Burosumab Sales by Type (2017-2022) & (K Units)
Table 55. Europe Burosumab Sales Market Share by Type (2017-2022)
Table 56. Europe Burosumab Sales by Application (2017-2022) & (K Units)
Table 57. Europe Burosumab Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Burosumab Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Burosumab Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Burosumab Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Burosumab Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Burosumab Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Burosumab Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Burosumab Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Burosumab Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Burosumab
Table 67. Key Market Challenges & Risks of Burosumab
Table 68. Key Industry Trends of Burosumab
Table 69. Burosumab Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Burosumab Distributors List
Table 72. Burosumab Customer List
Table 73. Global Burosumab Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Burosumab Sales Market Forecast by Region
Table 75. Global Burosumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Burosumab Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Burosumab Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Burosumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Burosumab Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Burosumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Burosumab Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Burosumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Burosumab Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Burosumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Burosumab Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Burosumab Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Burosumab Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Burosumab Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Burosumab Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Burosumab Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Burosumab Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Burosumab Revenue Market Share Forecast by Application (2023-2028)
Table 93. Ultragenyx Basic Information, Burosumab Manufacturing Base, Sales Area and Its Competitors
Table 94. Ultragenyx Burosumab Product Offered
Table 95. Ultragenyx Burosumab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Ultragenyx Main Business
Table 97. Ultragenyx Latest Developments
Table 98. Kyowa Kirin Basic Information, Burosumab Manufacturing Base, Sales Area and Its Competitors
Table 99. Kyowa Kirin Burosumab Product Offered
Table 100. Kyowa Kirin Burosumab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Kyowa Kirin Main Business
Table 102. Kyowa Kirin Latest Developments
Table 1. Burosumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Burosumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 10mg/mL
Table 4. Major Players of 20mg/mL
Table 5. Major Players of 30mg/mL
Table 6. Global Burosumab Sales by Type (2017-2022) & (K Units)
Table 7. Global Burosumab Sales Market Share by Type (2017-2022)
Table 8. Global Burosumab Revenue by Type (2017-2022) & ($ million)
Table 9. Global Burosumab Revenue Market Share by Type (2017-2022)
Table 10. Global Burosumab Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Burosumab Sales by Application (2017-2022) & (K Units)
Table 12. Global Burosumab Sales Market Share by Application (2017-2022)
Table 13. Global Burosumab Revenue by Application (2017-2022)
Table 14. Global Burosumab Revenue Market Share by Application (2017-2022)
Table 15. Global Burosumab Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Burosumab Sales by Company (2020-2022) & (K Units)
Table 17. Global Burosumab Sales Market Share by Company (2020-2022)
Table 18. Global Burosumab Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Burosumab Revenue Market Share by Company (2020-2022)
Table 20. Global Burosumab Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Burosumab Producing Area Distribution and Sales Area
Table 22. Players Burosumab Products Offered
Table 23. Burosumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Burosumab Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Burosumab Sales Market Share Geographic Region (2017-2022)
Table 28. Global Burosumab Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Burosumab Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Burosumab Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Burosumab Sales Market Share by Country/Region (2017-2022)
Table 32. Global Burosumab Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Burosumab Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Burosumab Sales by Country (2017-2022) & (K Units)
Table 35. Americas Burosumab Sales Market Share by Country (2017-2022)
Table 36. Americas Burosumab Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Burosumab Revenue Market Share by Country (2017-2022)
Table 38. Americas Burosumab Sales by Type (2017-2022) & (K Units)
Table 39. Americas Burosumab Sales Market Share by Type (2017-2022)
Table 40. Americas Burosumab Sales by Application (2017-2022) & (K Units)
Table 41. Americas Burosumab Sales Market Share by Application (2017-2022)
Table 42. APAC Burosumab Sales by Region (2017-2022) & (K Units)
Table 43. APAC Burosumab Sales Market Share by Region (2017-2022)
Table 44. APAC Burosumab Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Burosumab Revenue Market Share by Region (2017-2022)
Table 46. APAC Burosumab Sales by Type (2017-2022) & (K Units)
Table 47. APAC Burosumab Sales Market Share by Type (2017-2022)
Table 48. APAC Burosumab Sales by Application (2017-2022) & (K Units)
Table 49. APAC Burosumab Sales Market Share by Application (2017-2022)
Table 50. Europe Burosumab Sales by Country (2017-2022) & (K Units)
Table 51. Europe Burosumab Sales Market Share by Country (2017-2022)
Table 52. Europe Burosumab Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Burosumab Revenue Market Share by Country (2017-2022)
Table 54. Europe Burosumab Sales by Type (2017-2022) & (K Units)
Table 55. Europe Burosumab Sales Market Share by Type (2017-2022)
Table 56. Europe Burosumab Sales by Application (2017-2022) & (K Units)
Table 57. Europe Burosumab Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Burosumab Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Burosumab Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Burosumab Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Burosumab Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Burosumab Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Burosumab Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Burosumab Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Burosumab Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Burosumab
Table 67. Key Market Challenges & Risks of Burosumab
Table 68. Key Industry Trends of Burosumab
Table 69. Burosumab Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Burosumab Distributors List
Table 72. Burosumab Customer List
Table 73. Global Burosumab Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Burosumab Sales Market Forecast by Region
Table 75. Global Burosumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Burosumab Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Burosumab Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Burosumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Burosumab Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Burosumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Burosumab Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Burosumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Burosumab Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Burosumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Burosumab Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Burosumab Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Burosumab Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Burosumab Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Burosumab Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Burosumab Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Burosumab Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Burosumab Revenue Market Share Forecast by Application (2023-2028)
Table 93. Ultragenyx Basic Information, Burosumab Manufacturing Base, Sales Area and Its Competitors
Table 94. Ultragenyx Burosumab Product Offered
Table 95. Ultragenyx Burosumab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Ultragenyx Main Business
Table 97. Ultragenyx Latest Developments
Table 98. Kyowa Kirin Basic Information, Burosumab Manufacturing Base, Sales Area and Its Competitors
Table 99. Kyowa Kirin Burosumab Product Offered
Table 100. Kyowa Kirin Burosumab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Kyowa Kirin Main Business
Table 102. Kyowa Kirin Latest Developments
LIST OF FIGURES
Figure 1. Picture of Burosumab
Figure 2. Burosumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Burosumab Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Burosumab Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Burosumab Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 10mg/mL
Figure 10. Product Picture of 20mg/mL
Figure 11. Product Picture of 30mg/mL
Figure 12. Global Burosumab Sales Market Share by Type in 2021
Figure 13. Global Burosumab Revenue Market Share by Type (2017-2022)
Figure 14. Burosumab Consumed in Minor Patients Over 1 Year Old
Figure 15. Global Burosumab Market: Minor Patients Over 1 Year Old (2017-2022) & (K Units)
Figure 16. Burosumab Consumed in Adult Patients
Figure 17. Global Burosumab Market: Adult Patients (2017-2022) & (K Units)
Figure 18. Global Burosumab Sales Market Share by Application (2017-2022)
Figure 19. Global Burosumab Revenue Market Share by Application in 2021
Figure 20. Burosumab Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Burosumab Revenue Market Share by Company in 2021
Figure 22. Global Burosumab Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Burosumab Revenue Market Share by Geographic Region in 2021
Figure 24. Global Burosumab Sales Market Share by Region (2017-2022)
Figure 25. Global Burosumab Revenue Market Share by Country/Region in 2021
Figure 26. Americas Burosumab Sales 2017-2022 (K Units)
Figure 27. Americas Burosumab Revenue 2017-2022 ($ Millions)
Figure 28. APAC Burosumab Sales 2017-2022 (K Units)
Figure 29. APAC Burosumab Revenue 2017-2022 ($ Millions)
Figure 30. Europe Burosumab Sales 2017-2022 (K Units)
Figure 31. Europe Burosumab Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Burosumab Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Burosumab Revenue 2017-2022 ($ Millions)
Figure 34. Americas Burosumab Sales Market Share by Country in 2021
Figure 35. Americas Burosumab Revenue Market Share by Country in 2021
Figure 36. United States Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Burosumab Sales Market Share by Region in 2021
Figure 41. APAC Burosumab Revenue Market Share by Regions in 2021
Figure 42. China Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Burosumab Sales Market Share by Country in 2021
Figure 49. Europe Burosumab Revenue Market Share by Country in 2021
Figure 50. Germany Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Burosumab Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Burosumab Revenue Market Share by Country in 2021
Figure 57. Egypt Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Burosumab in 2021
Figure 63. Manufacturing Process Analysis of Burosumab
Figure 64. Industry Chain Structure of Burosumab
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 1. Picture of Burosumab
Figure 2. Burosumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Burosumab Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Burosumab Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Burosumab Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 10mg/mL
Figure 10. Product Picture of 20mg/mL
Figure 11. Product Picture of 30mg/mL
Figure 12. Global Burosumab Sales Market Share by Type in 2021
Figure 13. Global Burosumab Revenue Market Share by Type (2017-2022)
Figure 14. Burosumab Consumed in Minor Patients Over 1 Year Old
Figure 15. Global Burosumab Market: Minor Patients Over 1 Year Old (2017-2022) & (K Units)
Figure 16. Burosumab Consumed in Adult Patients
Figure 17. Global Burosumab Market: Adult Patients (2017-2022) & (K Units)
Figure 18. Global Burosumab Sales Market Share by Application (2017-2022)
Figure 19. Global Burosumab Revenue Market Share by Application in 2021
Figure 20. Burosumab Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Burosumab Revenue Market Share by Company in 2021
Figure 22. Global Burosumab Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Burosumab Revenue Market Share by Geographic Region in 2021
Figure 24. Global Burosumab Sales Market Share by Region (2017-2022)
Figure 25. Global Burosumab Revenue Market Share by Country/Region in 2021
Figure 26. Americas Burosumab Sales 2017-2022 (K Units)
Figure 27. Americas Burosumab Revenue 2017-2022 ($ Millions)
Figure 28. APAC Burosumab Sales 2017-2022 (K Units)
Figure 29. APAC Burosumab Revenue 2017-2022 ($ Millions)
Figure 30. Europe Burosumab Sales 2017-2022 (K Units)
Figure 31. Europe Burosumab Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Burosumab Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Burosumab Revenue 2017-2022 ($ Millions)
Figure 34. Americas Burosumab Sales Market Share by Country in 2021
Figure 35. Americas Burosumab Revenue Market Share by Country in 2021
Figure 36. United States Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Burosumab Sales Market Share by Region in 2021
Figure 41. APAC Burosumab Revenue Market Share by Regions in 2021
Figure 42. China Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Burosumab Sales Market Share by Country in 2021
Figure 49. Europe Burosumab Revenue Market Share by Country in 2021
Figure 50. Germany Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Burosumab Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Burosumab Revenue Market Share by Country in 2021
Figure 57. Egypt Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Burosumab Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Burosumab in 2021
Figure 63. Manufacturing Process Analysis of Burosumab
Figure 64. Industry Chain Structure of Burosumab
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
